Form 4: Thermo Fisher Scientific Executive Vice President Reports Stock Disposals Due to Performance-Based Vesting Adjustment

Frederick M. Lowery, Executive Vice President of Thermo Fisher Scientific, reports the disposal of shares due to an adjustment in a performance-based restricted stock unit award.

Summary

• Frederick M. Lowery, an Executive Vice President at Thermo Fisher Scientific, filed a Form 4 detailing changes in beneficial ownership.
• The filing reports the disposal of common stock on February 28, 2025, due to the vesting of a performance-based restricted stock unit award.
• The award, granted on February 23, 2022, vested in three tranches, with the final tranche vesting on February 28, 2025.
• The number of shares in the final tranche was adjusted downward by 30% based on the company's relative total shareholder return (TSR) over the period from January 1, 2022, to December 31, 2024.
• As a result, Lowery received 475.765, 208.388 and 812.763 less shares than initially reported.
• Lowery also reports acquiring 1.41 shares of TMO common stock under the TMO 401(k) plan between February 19, 2025, and February 28, 2025.
• Following the reported transactions, Lowery beneficially owns 15,035.0904 shares directly, 1,147.8 shares indirectly through a 401(k), and 5.036 shares indirectly through a Limited Liability Company.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document primarily reports transactions related to executive compensation. The downward adjustment of the performance-based award is a slight negative, but the overall impact is not significant.

Positives

• The vesting of the performance-based restricted stock unit award indicates that some performance metrics were met, even though the final tranche was adjusted downward.

Negatives

• The downward adjustment of the final tranche of the performance-based restricted stock unit award suggests that Thermo Fisher Scientific's relative total shareholder return (TSR) did not meet the highest performance threshold.

Risks

• Fluctuations in Thermo Fisher Scientific's stock price could impact the value of Lowery's holdings.
• Changes in company performance could affect future vesting of performance-based awards.

Industry Context

Executive compensation and stock ownership are common practices in publicly traded companies like Thermo Fisher Scientific to align management's interests with those of shareholders.

Comparison to Industry Standards

• Performance-based equity awards are a common component of executive compensation packages in the life sciences and diagnostics industries.
• Companies like Danaher, Agilent, and Illumina also utilize similar equity-based compensation plans to incentivize executives and align their interests with shareholder value creation.
• The specific metrics and vesting schedules vary across companies, but the general principle of linking executive pay to company performance is widely adopted.

Stakeholder Impact

• The vesting and adjustment of executive stock awards can impact shareholder perception of executive compensation and company performance.
• Employees may be affected by the company's TSR performance, which influences the vesting of performance-based awards.

Key Dates

Keywords

Form 4, Thermo Fisher Scientific, TMO, Frederick M. Lowery, Executive Vice President, Beneficial Ownership, Stock Disposal, Performance-Based Restricted Stock Unit, Vesting, Total Shareholder Return, 401(k)